You have high hopes for September @antibotter .... based on past performance I am not sure I would be so optimistic ?
I am looking forward to the Viraleze readouts but the DEP "top-line" readouts wont excite me unless they have a license deal attached .... and of course after the AZD0466 disaster you would think JF & Co. would have expedited the DEP readouts by now to compensate but apparently not ?
How hard can it be to collate top-line data from open label trials that have been going on for years and earlier patients would have a huge amount of data already recorded.... if it was full and final data I get why it would take the full 5-6 months but as indicated by the company on multiple occasions, the data is only going to be top-line data .... not looking good IMO if they wait until the very last minute (30 Sep) to announce or blow past the date yet again
SPL Price at posting:
14.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)